Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Botulinum toxin may reduce inflammation markers in head and neck conditions, but evidence is uncertain.

Women with hair loss often have deficiencies in iron, vitamins, minerals, and lower thyroid function, suggesting the need for nutritional and hormonal treatment.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Minoxidil, caffeine, and biotin can improve hair shine by restoring certain genes.

Protein carbonylation is a sensitive marker for oxidative damage in hair, especially from light exposure.

VLDL could be an early warning sign for male pattern baldness.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

BST2 is a key marker for hair loss disease alopecia areata.

People with alopecia areata have higher levels of a heart disease marker in their blood.

SHBG may be a useful early indicator and treatment target for PCOS.

Microvascular damage and platelet issues persist in ulcerative colitis remission, helping assess disease states.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Inflammasome proteins may help diagnose and treat Parkinson's disease.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

Human hair protein modifications could potentially indicate heart disease risk.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Small extracellular vesicles can help diagnose and manage sepsis.

Minoxidil is more effective than the botanical extract for hair loss, but the extract shows potential as an alternative.

KRT6A may help diagnose and treat alopecia areata.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.